Bromocriptine Mesylate (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Bromocriptine Mesylate drug offered from KAISER FOUNDATION HOSPITALS. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: bromocriptine mesylate
SUBSTANCE NAME: BROMOCRIPTINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ergolines [Chemical/Ingredient],Ergot Derivative [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-10-10
END MARKETING DATE: 0000-00-00


Bromocriptine Mesylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBromocriptine Mesylate from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2014-10-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0165_c803f04c-c4e0-4120-88e8-86a721323987
PRODUCT NDC: 0179-0165
APPLICATION NUMBER: ANDA076962

Other BROMOCRIPTINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingBromocriptine Mesylate
Avera McKennan HospitalBromocriptine Mesylate
Cadila Healthcare LimitedBromocriptine mesylate
Carilion Materials ManagementBromocriptine mesylate
KAISER FOUNDATION HOSPITALSBromocriptine Mesylate
Mylan Pharmaceuticals Inc.Bromocriptine Mesylate
Paddock Laboratories, LLCBromocriptine mesylate
Physicians Total Care, Inc.Bromocriptine Mesylate
Ranbaxy Pharmaceuticals Inc.BROMOCRIPTINE MESYLATE
Sandoz IncBromocriptine mesylate
Santarus, Inc.CYCLOSET
Validus Pharmaceuticals LLCParlodel
Zydus Pharmaceuticals (USA) Inc.Bromocriptine mesylate